These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10229992)

  • 21. [Clinical experience with the vasoconstrictor action of H 1032 on the nasal mucosa].
    Carta F
    Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1967; 78(4):510-9. PubMed ID: 4180004
    [No Abstract]   [Full Text] [Related]  

  • 22. Influenza Antiviral Expenditures and Outpatient Prescriptions in the United States, 2003-2012.
    Suda KJ; Hunkler RJ; Matusiak LM; Schumock GT
    Pharmacotherapy; 2015 Nov; 35(11):991-7. PubMed ID: 26598091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Decongestants in treatment of nasal obstruction].
    Bogacka E
    Otolaryngol Pol; 1999; 53(3):347-52. PubMed ID: 10481510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(195):58974-7. PubMed ID: 16217879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A topical nasal decongestant for children.
    Neffson AH
    Eye Ear Nose Throat Mon; 1968 Mar; 47(3):121-3. PubMed ID: 4171734
    [No Abstract]   [Full Text] [Related]  

  • 27. Physiologic and clinical estimates of the relief of nasal flow obstruction in allergic rhinitis: effects of a topical decongestant (oxymetazoline).
    Cohen BM; Duffy EP
    J Asthma Res; 1969 Dec; 7(2):65-73. PubMed ID: 4189976
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical nasal decongestants.
    Engle JP
    Am Pharm; 1992 May; NS32(5):33-7. PubMed ID: 1375430
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical use of Nasibin for chronic sinusitis].
    Tanaka M
    Jibiinkoka; 1966 Nov; 38(11):1205-8. PubMed ID: 4167237
    [No Abstract]   [Full Text] [Related]  

  • 30. Over-the-counter sales of drugs in Sweden 1976-1983.
    Wessling A
    Eur J Clin Pharmacol; 1987; 33(1):1-6. PubMed ID: 3691589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Stringan: decongestant and nasal anti-inflammatory agent].
    Truffer E
    Rev Med Suisse Romande; 1968 Jun; 88(6):419-26. PubMed ID: 4190158
    [No Abstract]   [Full Text] [Related]  

  • 32. A trial of Iliadin in non-specific allergic rhinitis.
    Leitch GB
    Br J Clin Pract; 1976 Feb; 30(2):37-42. PubMed ID: 56185
    [No Abstract]   [Full Text] [Related]  

  • 33. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold.
    Strandell B; Norgren-Holst E; Tran N; Jakobsen HB; Chen S
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):744-51. PubMed ID: 19954713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.
    Frisk P; Sporrong SK; Ljunggren G; Wettermark B; von Euler M
    Eur J Clin Pharmacol; 2016 Jun; 72(6):747-54. PubMed ID: 26922586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Investigation of the effect of oxymetazoline on the duration of rhinitis. results of a placebo-controlled double-blind study in patients with acute rhinitis].
    Reinecke S; Tschaikin M
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():113-8. PubMed ID: 16261947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic prescriptions for outpatient acute rhinosinusitis in Canada, 2007-2013.
    Sharma P; Finley R; Weese S; Glass-Kaastra S; McIsaac W
    PLoS One; 2017; 12(7):e0181957. PubMed ID: 28750020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs.
    Dhippayom T; Walker R
    Pharm World Sci; 2006 Aug; 28(4):194-8. PubMed ID: 17066243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of nasal decongestants on locomotor activity of the ciliary apparatus of nasal mucosa in patients with acute purulent rhinosinusitis].
    Kramnoĭ AI; Kozlov VS
    Vestn Otorinolaringol; 2010; (1):67-8. PubMed ID: 20436429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.
    Wettermark B; Hammar N; Fored CM; Leimanis A; Otterblad Olausson P; Bergman U; Persson I; Sundström A; Westerholm B; Rosén M
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):726-35. PubMed ID: 16897791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nasal toilet in infants with rhinitis: nasal passage crucial, so treat with xylometazoline].
    Mensink MHA; Wieringa N; Videler W; Klok T
    Ned Tijdschr Geneeskd; 2022 May; 166():. PubMed ID: 35736357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.